# BIBF 1120 for Recurrent High-Grade Gliomas

> **NCT01380782** · PHASE2 · COMPLETED · sponsor: **Patrick Y. Wen, MD** · enrollment: 37 (actual)

## Conditions studied

- Glioblastoma
- Gliosarcoma
- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma
- Anaplastic Oligoastrocytoma

## Interventions

- **DRUG:** BIBF 1120

## Key facts

- **NCT ID:** NCT01380782
- **Lead sponsor:** Patrick Y. Wen, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-07
- **Final completion:** 2014-07
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2014-08-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380782, "BIBF 1120 for Recurrent High-Grade Gliomas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01380782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*